Creatine kinase and its MB isoenzyme in the third trimester and the peripartum period

Gary S Leiserowitz, A. T. Evans, S. J. Samuels, K. Omand, Gerald J Kost

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Forty-nine normal pregnant women were recruited late in the third trimester for serial determinations of creatine kinase (CK) and its MB isoenzyme fraction (CK-MB) at four different times: (1) on recruitment between 36 and 40 weeks' gestation, (2) on admission in active labor, (3) immediately after delivery, and (4) on the first postpartum day. In the patients with vaginal delivery (n = 43) total CK was significantly elevated at time 4 compared with times 1, 2 and 3 (P value < .0001). CK-MB fraction was also significantly elevated at time 4 compared with times 1, 2 and 3 (P value < .0001). In 35.7% of the patients at time 4, CK-MB was sufficiently elevated to give the laboratory interpretation of 'borderline' or 'consistent with a myocardial infarction,' even though none of the patients had cardiac symptoms or complications. A review of the literature shows that CK-MB is found not only in myocardium but also in uterus and placenta. The implication of this study is that elevations in total CK and CK-MB should be used with caution during the peripartum period to diagnose myocardial ischemia or infarction.

Original languageEnglish (US)
Pages (from-to)910-916
Number of pages7
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume37
Issue number11
StatePublished - 1992
Externally publishedYes

Fingerprint

Peripartum Period
MB Form Creatine Kinase
Third Pregnancy Trimester
Isoenzymes
Creatine Kinase
Myocardial Infarction
Postpartum Period
Placenta
Uterus
Myocardial Ischemia
Pregnant Women
Myocardium
Pregnancy

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Creatine kinase and its MB isoenzyme in the third trimester and the peripartum period. / Leiserowitz, Gary S; Evans, A. T.; Samuels, S. J.; Omand, K.; Kost, Gerald J.

In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 37, No. 11, 1992, p. 910-916.

Research output: Contribution to journalArticle

@article{41fa896952b846f684c2e84344a0c119,
title = "Creatine kinase and its MB isoenzyme in the third trimester and the peripartum period",
abstract = "Forty-nine normal pregnant women were recruited late in the third trimester for serial determinations of creatine kinase (CK) and its MB isoenzyme fraction (CK-MB) at four different times: (1) on recruitment between 36 and 40 weeks' gestation, (2) on admission in active labor, (3) immediately after delivery, and (4) on the first postpartum day. In the patients with vaginal delivery (n = 43) total CK was significantly elevated at time 4 compared with times 1, 2 and 3 (P value < .0001). CK-MB fraction was also significantly elevated at time 4 compared with times 1, 2 and 3 (P value < .0001). In 35.7{\%} of the patients at time 4, CK-MB was sufficiently elevated to give the laboratory interpretation of 'borderline' or 'consistent with a myocardial infarction,' even though none of the patients had cardiac symptoms or complications. A review of the literature shows that CK-MB is found not only in myocardium but also in uterus and placenta. The implication of this study is that elevations in total CK and CK-MB should be used with caution during the peripartum period to diagnose myocardial ischemia or infarction.",
author = "Leiserowitz, {Gary S} and Evans, {A. T.} and Samuels, {S. J.} and K. Omand and Kost, {Gerald J}",
year = "1992",
language = "English (US)",
volume = "37",
pages = "910--916",
journal = "The Journal of reproductive medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "11",

}

TY - JOUR

T1 - Creatine kinase and its MB isoenzyme in the third trimester and the peripartum period

AU - Leiserowitz, Gary S

AU - Evans, A. T.

AU - Samuels, S. J.

AU - Omand, K.

AU - Kost, Gerald J

PY - 1992

Y1 - 1992

N2 - Forty-nine normal pregnant women were recruited late in the third trimester for serial determinations of creatine kinase (CK) and its MB isoenzyme fraction (CK-MB) at four different times: (1) on recruitment between 36 and 40 weeks' gestation, (2) on admission in active labor, (3) immediately after delivery, and (4) on the first postpartum day. In the patients with vaginal delivery (n = 43) total CK was significantly elevated at time 4 compared with times 1, 2 and 3 (P value < .0001). CK-MB fraction was also significantly elevated at time 4 compared with times 1, 2 and 3 (P value < .0001). In 35.7% of the patients at time 4, CK-MB was sufficiently elevated to give the laboratory interpretation of 'borderline' or 'consistent with a myocardial infarction,' even though none of the patients had cardiac symptoms or complications. A review of the literature shows that CK-MB is found not only in myocardium but also in uterus and placenta. The implication of this study is that elevations in total CK and CK-MB should be used with caution during the peripartum period to diagnose myocardial ischemia or infarction.

AB - Forty-nine normal pregnant women were recruited late in the third trimester for serial determinations of creatine kinase (CK) and its MB isoenzyme fraction (CK-MB) at four different times: (1) on recruitment between 36 and 40 weeks' gestation, (2) on admission in active labor, (3) immediately after delivery, and (4) on the first postpartum day. In the patients with vaginal delivery (n = 43) total CK was significantly elevated at time 4 compared with times 1, 2 and 3 (P value < .0001). CK-MB fraction was also significantly elevated at time 4 compared with times 1, 2 and 3 (P value < .0001). In 35.7% of the patients at time 4, CK-MB was sufficiently elevated to give the laboratory interpretation of 'borderline' or 'consistent with a myocardial infarction,' even though none of the patients had cardiac symptoms or complications. A review of the literature shows that CK-MB is found not only in myocardium but also in uterus and placenta. The implication of this study is that elevations in total CK and CK-MB should be used with caution during the peripartum period to diagnose myocardial ischemia or infarction.

UR - http://www.scopus.com/inward/record.url?scp=0026539709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026539709&partnerID=8YFLogxK

M3 - Article

VL - 37

SP - 910

EP - 916

JO - The Journal of reproductive medicine

JF - The Journal of reproductive medicine

SN - 0024-7758

IS - 11

ER -